Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?

被引：2

作者：

Coiffier, B ^{[1
]}

机构：

[1] Hospices Civils Lyon, Dept Hematol, Lyon, France

来源：

NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 08期

关键词：

bortezomib; non-Hodgkin's lymphoma; mantle-cell lymphoma;

D O I：

10.1038/ncponc0229

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：388 / 389

页数：2

共 5 条

[1] The proteasome: A suitable antineoplastic target [J].

Adams, J .

NATURE REVIEWS CANCER, 2004, 4 (05) :349-360

[2] Dose intensity or monoclonal antibody in first-line treatment [J].

Coiffier, B .

HEMATOLOGY JOURNAL, 2004, 5 :S154-S158

[3]

Coiffier Bertrand, 2005, Oncology (Williston Park), V19, P7

[4] Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte [J].

Feugier, P ;

Van Hoof, A ;

Sebban, C ;

Solal-Celigny, P ;

Bouabdallah, R ;

Fermé, C ;

Christian, B ;

Lepage, E ;

Tilly, H ;

Morschhauser, F ;

Gaulard, P ;

Salles, G ;

Bosly, A ;

Gisselbrecht, C ;

Reyes, F ;

Coiffier, B .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4117-4126

[5] Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-Cell non-Hodgkin's lymphoma [J].

Goy, A ;

Younes, A ;

McLaughlin, P ;

Pro, B ;

Romaguera, JE ;

Hagemeister, F ;

Fayad, L ;

Dang, NH ;

Samaniego, F ;

Wang, M ;

Broglio, K ;

Samuels, B ;

Gilles, F ;

Sarris, AH ;

Hart, S ;

Trehu, E ;

Schenkein, D ;

Cabanillas, F ;

Rodriguez, AM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :667-675

← 1 →